Konica lands generic x-ray contrast agent

Article

Konica Corp. has signed an agreement with Fuji Pharmaceuticalfor Japanese sales of Oiparomin, a generic x-ray contrast agent,according to Japan's Comline Business Data. The agent was approvedby the country's Ministry of Health and Welfare in March and

Konica Corp. has signed an agreement with Fuji Pharmaceuticalfor Japanese sales of Oiparomin, a generic x-ray contrast agent,according to Japan's Comline Business Data. The agent was approvedby the country's Ministry of Health and Welfare in March and aproduct launch will occur as soon as final pricing approval isreceived in July, Comline said.

Related Videos
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Emerging Innovations in Molecular Imaging
Related Content
© 2023 MJH Life Sciences

All rights reserved.